Recombinant:Article Title: Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2 μL of 100 μM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1 μL of 20 μM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12 μL Primary Cell P3 Nucleofector solution (Lonza, V4XP-3032) and incubating at RT for 20 min. To 2.5x10 5 cells in 5 μL Nucelofector solution, 0.8 μL of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15 μL of the RNP solution and mixed by pipetting.
Article Title: Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity.
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2 mL of 100 mM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1 mL of 20 mM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12 mL Primary Cell P3 Nucleofector solution (Lonza, V4XP-3032) and incubating at RT for 20 min. To 2.5x105 cells in 5 mL Nucelofector solution, 0.8 mL of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15 mL of the RNP solution and mixed by pipetting.
Article Title: SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancer
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2μl of 100 μM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1μl of 20μM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12μl Primary Cell P3 Nucleofector solution (Lonza, V4XP- 3032) and incubating at RT for 20 min. To 2.5×10 5 cells in 5μl Nucleofector solution, 0.8μl of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15μl of the RNP solution and mixed by pipetting.
Electroporation:Article Title: Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2 μL of 100 μM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1 μL of 20 μM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12 μL Primary Cell P3 Nucleofector solution (Lonza, V4XP-3032) and incubating at RT for 20 min. To 2.5x10 5 cells in 5 μL Nucelofector solution, 0.8 μL of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15 μL of the RNP solution and mixed by pipetting.
Article Title: Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity.
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2 mL of 100 mM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1 mL of 20 mM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12 mL Primary Cell P3 Nucleofector solution (Lonza, V4XP-3032) and incubating at RT for 20 min. To 2.5x105 cells in 5 mL Nucelofector solution, 0.8 mL of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15 mL of the RNP solution and mixed by pipetting.
Article Title: SOX2 drives fetal reprogramming and reversible dormancy in colorectal cancer
Article Snippet: Ribonucleoprotein (RNP) complexes were formed by diluting 2μl of 100 μM of multi-gRNA (Synthego) in Tris-EDTA (TE) (Synthego) and 1μl of 20μM recombinant Cas-9 (Integrated DNA Technologies (IDT), 1081059) in RNase-free PBS in 12μl Primary Cell P3 Nucleofector solution (Lonza, V4XP- 3032) and incubating at RT for 20 min. To 2.5×10 5 cells in 5μl Nucleofector solution, 0.8μl of Electroporation Enhancer Solution (IDT, Alt-R Cas9 Electroporation Enhancer, 2 nmol) was added, followed by 15μl of the RNP solution and mixed by pipetting.
|